CClinicalTrials.gg
Status unknownNCT04346602Updated Apr 15, 2020

A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019

An observational study in COVID-2019, sponsored by Jilin University. Status unknown at 1 site in China. Open to participants aged 1 Year to 80 Years. Per ClinicalTrials.gov, last updated 2020-04-15.

Sponsored by Jilin University · Observational

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
132
Ages
1 Year to 80 Years
Sex
All
01

Study summary

A study on the clinical and psychological characteristics of patients with coronavirus disease 2019 (COVID-2019)

Read the detailed description

The main objective of this study is to study the clinical and psychological responses of patients with COVID-2019 during the whole treatment process. Including clinical symptoms, auxiliary examination results, and corresponding psychological changes, including depression, anxiety, insomnia, etc. This study will draw lessons about treatment and other better advices for other countries and regions.

02

Conditions studied

  • COVID-2019

Keywords

  • COVID-2019
  • clinical
  • psychological
  • symptom
03

In context

Lead sponsor

Jilin University is the lead sponsor of 26 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients with COVID-2019 would be observed.

Inclusion criteria

  • patients with COVID-2019

Exclusion criteria

Exclusion Criteria:

  • No
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
132 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients with COVID-2019

    Patients with COVID-2019 would be observed.

    Other: all treatment about COVID-2019

Interventions

  • Otherall treatment about COVID-2019

    All patients with COVID-2019 would receive treatment provided by the government and should comply with relevant laws and regulations.

06

What researchers measure

Primary outcomes

  1. fever

    The fever is one main clinical characteristics of patients with COVID-2019, Measured by thermometer. 37.2-38 degrees Celsius, low fever; 38-39 degrees Celsius, moderate fever; 39-40 degrees Celsius, high fever.

    Time frame: one month

Secondary outcomes

  1. cough

    Cough is one main symptom of patients with COVID-2019. "Yes" or "no" would be recorded.

    Time frame: one month

  2. diarrhea

    Diarrhea is one symptom of some patients with COVID-2019. "Yes" or "no" would be recorded.

    Time frame: one month

  3. anxiety

    Anxiety is one main psychological characteristic of patients with COVID-2019. It would be assessed by Hamilton anxiety scale (HAMA). Scores of HAMA were positively correlated with the severity of anxiety.

    Time frame: two months

  4. insomnia

    Insomnia is one main psychological characteristic of patients with COVID-2019. It would be assessed by Athens insomnia scale (AIS). Scores of AIS were positively correlated with the severity of insomnia.

    Time frame: two months

  5. depression

    Depression is one psychological characteristic of patients with COVID-2019.It would be assessed by Hamilton Depression Rating Scale (HAMD) . Scores of HAMD were positively correlated with the severity of depression.

    Time frame: two months

07

Study locations

1 of 1 sites recruiting
  • the First Hospital of Jilin University
    Chang chun, Jilin 130021, China
    • Dong Yang, Master · Contact
    • Dong Yang, Master · Sub investigator
    Recruiting
08

References and documents

Publications

  • Yan B, Song L, Guo J, Wang Y, Peng L, Li D. Association Between Clinical Characteristics and Short-Term Outcomes in Adult Male COVID-19 Patients With Mild Clinical Symptoms: A Single-Center Observational Study. Front Med (Lausanne). 2021 Jan 5;7:571396. doi: 10.3389/fmed.2020.571396. eCollection 2020. PubMed 33469542 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04346602
Lead sponsor
Jilin University
Responsible party
Dong Yang (Doctor, Jilin University) — Principal investigator
First posted
Apr 15, 2020
Start date
Feb 1, 2020
Primary completion
Jun 1, 2020 (estimated)
Completion
Dec 1, 2020 (estimated)
Last update
Apr 15, 2020

Study contacts

Bai ling Yan, Doctor
Contact
yanbailing@163.com
15804300278
Dong Yang, Master
Contact
714488468@qq.com
18844097668
Dong Yang, Master
principal investigator · The First Hospital of Jilin University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion